Thermo Fisher to Buy Back Stock | GenomeWeb
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Thursday that its board of directors has authorized the repurchase of up to $500 million of the firm’s common stock on the open market through Sept. 10, 2009.
 
The firm’s board had authorized a $1 billion share repurchase program from August 2007 to August 2008.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.